National PBM Drug Monograph

Blood Pressure. There was a dose-dependent decrease in systolic blood pressure with canagliflozin relative to placebo or active comparator. Mean changes across studies ranged from -0.1 to -6.1mmHg. All results were considered significant except for the placebo-controlled studies combining canagliflozin and sulfonylureas (Table 11). ................
................